Shenouda Maged
Transaction: 12/15/2025
BUY
Change
+11,665
Price
$4.12
Filing
12/16/2025
Type
BUY
Relmada Therapeutics, Inc.
RLMD • Biotechnology
$4.43
▲ +0.06 (+1.37%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$497.83M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 14.62Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.43
Change1.37%
Shares Out112.38M
Market Cap$497.83M
Enterprise Value$280.09M
52W Range0.52 - 8.00
Beta0.39
P/E-8.04
P/B2.41
P/FCF-8.15
EV/EBITDA-4.44
EV/FCF-4.59
Price$4.43
Change1.37%
Shares Out112.38M
Market Cap$497.83M
Enterprise Value$280.09M
52W Range0.52 - 8.00
Beta0.39
P/E-8.04
P/B2.41
P/FCF-8.15
EV/EBITDA-4.44
EV/FCF-4.59
Earnings Yield-12.44%
FCF Yield-12.27%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio14.62
Quick Ratio14.62
Revenue 5Y-100.00%
Target$11.00
Target Upside148.31%
Target Median$11.00
Target Range10.00 - 12.00
Volume1.44M
Avg Volume1.28M
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
85/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 14.62Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
75/100
Bullish
Bullish
5
Hold
2
Bearish
1
Price Target
2026-08-07
Low
$10.00
Mean
$11.00
Median
$11.00
High
$12.00
Insider Transactions
Recent executive and insider activity
TRAVERSA SERGIO
Transaction: 12/15/2025
BUY
Change
+27,500
Price
$4.12
Filing
12/16/2025
Type
BUY
CASAMENTO CHARLES J
Transaction: 12/12/2025
BUY
Change
+164,000
Price
$4.06
Filing
12/16/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Shenouda Maged | BUY | +11,665 | $4.12 | 12/15/2025 | 12/16/2025 |
| TRAVERSA SERGIO | BUY | +27,500 | $4.12 | 12/15/2025 | 12/16/2025 |
| CASAMENTO CHARLES J | BUY | +164,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| Kelly Paul Edward | BUY | +828,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| GLASSPOOL JOHN | BUY | +164,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| Fedeli Fabiana | BUY | +164,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| Ence Chuck | BUY | +828,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| Shenouda Maged | BUY | +828,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| TRAVERSA SERGIO | BUY | +1,198,000 | $4.06 | 12/12/2025 | 12/16/2025 |
| Kelly Paul Edward | BUY | +90,000 | $2.20 | 11/05/2025 | 11/06/2025 |
| TRAVERSA SERGIO | BUY | +272,500 | $2.20 | 11/05/2025 | 11/06/2025 |
| Ence Chuck | BUY | +136,000 | $2.20 | 11/05/2025 | 11/06/2025 |
| Shenouda Maged | BUY | +500,000 | $2.20 | 11/05/2025 | 11/06/2025 |
| TRAVERSA SERGIO | BUY | +55,976 | $0.74 | 08/28/2025 | 08/28/2025 |
| TRAVERSA SERGIO | BUY | +129,455 | $0.67 | 08/27/2025 | 08/28/2025 |
| TRAVERSA SERGIO | BUY | +80,545 | $0.62 | 08/26/2025 | 08/28/2025 |
| Kelly Paul Edward | BUY | +400,000 | $0.67 | 06/26/2025 | 06/30/2025 |
| Fedeli Fabiana | BUY | +100,000 | $0.67 | 06/26/2025 | 06/30/2025 |
| GLASSPOOL JOHN | BUY | +100,000 | $0.67 | 06/26/2025 | 06/30/2025 |
| CASAMENTO CHARLES J | BUY | +100,000 | $0.67 | 06/26/2025 | 06/30/2025 |